HealthUnlocked

CorEvitas® IBD Registry Launches Precision Medicine Program to Expand Treatment Insights & Advance Care

Retrieved on: 
Thursday, September 29, 2022

CorEvitas IBD Registry launches biospecimen study to expand treatment insights and advance patient care.

Key Points: 
  • CorEvitas IBD Registry launches biospecimen study to expand treatment insights and advance patient care.
  • This biospecimen study will enable our industry partners to uncover even deeper clinical insights to optimize care for every patient in the future, no matter their phenotype," said Austin Read, Vice President, Precision Medicine at CorEvitas.
  • CorEvitas' ability to collect rich longitudinal clinical data alongside biospecimens through its IBD Registry is quite timely, paving the way for the next wave of IBD therapeutics and diagnostics.
  • The Precision Medicine business advances the molecular understanding of disease and prognostic tools by pairing registry data with select biospecimens and 'omics data.

CorEvitas, LLC Announces Expanded Specialty EMR Data Services

Retrieved on: 
Wednesday, July 6, 2022

and LONDON, July 6, 2022 /PRNewswire/ --CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit.

Key Points: 
  • and LONDON, July 6, 2022 /PRNewswire/ --CorEvitas, LLC is excited to announce expanded services to include specialty EMR data through its Specialty EMR Data Business Unit.
  • The organization is poised to offer expanded real-world data sets and innovative and customized technology solutions as it rebrands and fully integrates with CorEvitas.
  • CorEvitas, LLC expands real-world evidence services to include specialty EMR data.
  • The Specialty EMR Data business provides access to curated data sets including U.S. retinal EMR data, as well as UK and European primary and secondary care datasets to advance the understanding of population health.

CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR

Retrieved on: 
Thursday, May 12, 2022

WALTHAM, Mass. and BOWIE, Md., May 12, 2022 /PRNewswire/ -- CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announce a joint educational symposium at the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) annual meeting, being held in Washington, DC, from May 15-18, 2022.

Key Points: 
  • "Combining claims data with patient registry data presents the patient's lived experience, from medication adherence and hospital visits to pharmacy refills and socioeconomic factors."
  • However, these data are limited, typically only including patient demographics, diagnoses, procedures, and pharmacy script data.
  • By linking administrative claims data with clinical registry data, additional dimension is gained on both the patient journey and treatment experience.
  • The Precision Medicine business advances the molecular understanding of disease and prognostic tools by pairing registry data with select biospecimens and 'omics data.

CorEvitas, LLC Announces Executive Leadership Promotions

Retrieved on: 
Tuesday, April 26, 2022

and ARLINGTON, Va., April 26, 2022 /PRNewswire/ --CorEvitas, LLC is excited to announce leadership changes for HealthiVibe, its market-leading Patient Experience business.

Key Points: 
  • and ARLINGTON, Va., April 26, 2022 /PRNewswire/ --CorEvitas, LLC is excited to announce leadership changes for HealthiVibe, its market-leading Patient Experience business.
  • The company continues to grow and integrate the patient voice with its real-world evidence model bringing increased value to pharmaceutical clients - from discovery through commercialization.
  • Abbe Steel, founder and former CEO of HealthiVibe, is moving into the role of Chief Growth Officer with CorEvitas.
  • The Patient Experience business will be well-positioned for the future with the promotions of Jennifer Kelly, former Vice President of Operations, and Valerie Powell, former Vice President of Research Services.

New online community to provide important support to chronic pancreatitis patients.

Retrieved on: 
Tuesday, November 16, 2021

The online community is a much-needed space for patients who are suffering from this debilitating and isolating disease to connect and share their journey with pancreatitis in a supportive environment.

Key Points: 
  • The online community is a much-needed space for patients who are suffering from this debilitating and isolating disease to connect and share their journey with pancreatitis in a supportive environment.
  • Patients can join the community by following this link: https://healthunlocked.com/pancreatitis-support
    "Chronic pancreatitis is a chronic inflammatory destructive disease of the pancreas associated with multiple consequences including pancreatic exocrine insufficiency.
  • "Aimmune is committed to further understanding the impact of EPI on the quality of patients' lives with chronic pancreatitis," said Mohamed Yassine, MD.
  • Clinicians, the NHS (including NHS Choices), insurers and industry can use HealthUnlocked to link up with patients safely online.

CorEvitas and Inovalon Leverage Advanced Analytics to Deliver A Holistic View of the Patient

Retrieved on: 
Tuesday, September 21, 2021

"We are excited to collaborate with CorEvitas to accelerate these insights with an initial focus on rheumatoid arthritis and psoriasis."

Key Points: 
  • "We are excited to collaborate with CorEvitas to accelerate these insights with an initial focus on rheumatoid arthritis and psoriasis."
  • Insights made possible through these analytics can advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans.
  • Raymond Hill, Chairman and Chief Executive Officer for CorEvitas, noted, "As an organization, we recognize the immeasurable value of understanding the whole patient.
  • By furthering our collaboration with Inovalon, we can leverage the data-driven insights that provide integrated and actionable insights for the patient.

CorEvitas Announces First Patient Enrollment in a New Biorepository Study focused on Precision Medicine for JAK Inhibitors in Rheumatoid Arthritis

Retrieved on: 
Tuesday, August 10, 2021

Eligible rheumatology registry patients will contribute biological specimens that will be linked to longitudinal provider reported clinical and patient reported outcomes.

Key Points: 
  • Eligible rheumatology registry patients will contribute biological specimens that will be linked to longitudinal provider reported clinical and patient reported outcomes.
  • "We are excited to launch this biospecimen study to help advance the development of personalized therapies and diagnostics for rheumatology patients.
  • CorEvitas previously conducted the largest and most comprehensive clinical study comparing the effectiveness of patients starting or switching biologic agents for rheumatoid arthritis in the CERTAIN [Comparative Effectiveness Registry to Study Therapeutics for Arthritis and Inflammatory Conditions] study.
  • With our new JAK inhibitor precision medicine study, we anticipate advancing our understanding to predict which patients will be more likely to respond to JAK inhibitors," said Dr. Jeff Greenberg, Chief Medical Officer of CorEvitas.

My MSAA Community - Recognizing Five Years of Support from the Multiple Sclerosis Association of America

Retrieved on: 
Thursday, June 17, 2021

CHERRY HILL, N.J., June 17, 2021 /PRNewswire/ --The Multiple Sclerosis Association of America's (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since its creation in 2016.

Key Points: 
  • CHERRY HILL, N.J., June 17, 2021 /PRNewswire/ --The Multiple Sclerosis Association of America's (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since its creation in 2016.
  • Powered by HealthUnlocked, My MSAA Community offers people with multiple sclerosis, care partners, friends, and family members a way to connect with others also affected by the condition.
  • With more than 6,600 members, My MSAA Community serves as a safe space for people living with MS to share their experiences.
  • The Multiple Sclerosis Association of America (MSAA) is a national nonprofit organization and leading resource for the entire MS community, improving lives today through vital services and support.

Corrona Acquires HealthUnlocked, Creating a First-in-Class Patient Experience Ecosystem

Retrieved on: 
Tuesday, October 13, 2020

and LONDON, Oct. 13, 2020 /PRNewswire/ -- Corrona, LLC ("Corrona") , a built-for-purpose source of gold-standard real-world evidence, announced that it has acquired HealthUnlocked , the world's largest virtual patient community.

Key Points: 
  • and LONDON, Oct. 13, 2020 /PRNewswire/ -- Corrona, LLC ("Corrona") , a built-for-purpose source of gold-standard real-world evidence, announced that it has acquired HealthUnlocked , the world's largest virtual patient community.
  • Corrona's investment in HealthUnlocked helps to further expand the patient engagement offerings that began in late 2019 with Corrona's acquisition of HealthiVibe, a recognized leader in patient experience and engagement.
  • HealthUnlocked will be integrated into Corrona's HealthiVibe business unit to establish an innovative and holistic snapshot of the patient.
  • By building out its patient experience business, Corrona is working to create an industry-leading ecosystem centered around the patient voice.

MSAA Offers a Free Online Support Forum to Connect Members of the MS Community

Retrieved on: 
Thursday, June 27, 2019

CHERRY HILL, N.J., June 27, 2019 /PRNewswire/ --The Multiple Sclerosis Association of America's (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since the Summer of 2016.

Key Points: 
  • CHERRY HILL, N.J., June 27, 2019 /PRNewswire/ --The Multiple Sclerosis Association of America's (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since the Summer of 2016.
  • Powered by HealthUnlocked, My MSAA Community was created to offer people with multiple sclerosis, care partners, friends, and family members a way to connect with others also affected by the condition.
  • In addition to the daily interactions on the platform between members, MSAA also hosts frequent Ask Me Anything (AMA) events on the Community.
  • The Multiple Sclerosis Association of America (MSAA) is a national nonprofit organization and leading resource for the entire MS community, improving lives today through vital services and support.